NEUROONE MEDICAL TECHNOLOGIES CORP - Q3 FY2026 PRODUCT REVENUE INCREASED 16% TO $2 MLN; Q3 SHR LOSS $0.28 - SEC FILING

Reuters · 2d ago

Please log in to view news